A. Govoni

Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy type 1 (STR1VE-EU): an open-label, single-arm, multicentre, phase 3 trial

S. Corti, M. Pane, E. Mercuri, 2021, The Lancet Neurology.

Gut dysmotility in children with neurological impairment: the nutritional management

G. Zuccotti, E. Verduci, F. Gottrand, 2023, Frontiers in Neurology.

Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1

V. Calcaterra, V. Fabiano, D. Dilillo, 2021, Nutrients.

Protective Strategies of Haberlea rhodopensis for Acquisition of Freezing Tolerance: Interaction between Dehydration and Low Temperature

J. García-Plazaola, B. Fernández-Marín, J. Vilas, 2022, International journal of molecular sciences.

Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1

V. Calcaterra, V. Fabiano, D. Dilillo, 2021, Nutrients.